{"data":{"id":"us-dc/d.c.-code-7-3202","jurisdiction":"us-dc","citation":"D.C. Code § 7-3202","heading":"Expanding access to opioid use disorder treatment.","body":"(a)\n(1)\nBy January 1, 2020, each health insurer shall:\n(A)\nCreate a list of its in-network health care providers that treat opioid use disorder, including the in-network health provider's contact information and an indication of whether the in-network health care provider has been certified by the United States Drug Enforcement Agency to prescribe opioid use disorder treatment medication; and\n(B)\nMaintain at least one in-network health care provider who is accepting new patients and is authorized to treat opioid use disorder, including through the use of opioid use disorder treatment medication. Services delivered through telehealth may satisfy the requirement of this subparagraph.\n(2)\nEach health insurer shall update the list required by paragraph (1)(A) of this subsection on a quarterly basis.\n(3)\n(A)\nUpon the request of a beneficiary or prospective beneficiary of a health insurer, the health insurer shall transmit the list created and updated pursuant to paragraph (1) of this subsection to that beneficiary or prospective beneficiary by mail or by electronic means within 7 days after the receipt of the request.\n(B)\nEach health insurer shall publish the list and instructions on how to access the list created and updated pursuant to paragraphs (1) and (2) of this subsection on its website.\n\n(b)\nBy January 1, 2020, and annually thereafter:\n(1)\nEach health insurer shall submit a report to DBH, DHCF, DISB, and the Council that includes the following:\n(A)\nA list of the health insurer's in-network health care providers that are certified by the United States Drug Enforcement Agency to prescribe opioid use disorder treatment medications, and which type of opioid use disorder treatment medications the health care providers prescribe;\n(B)\nThe number of beneficiaries that were treated for opioid use disorder in the prior fiscal year; and\n(C)\nA description of any efforts by the health insurer in the prior fiscal year to ensure that its in-network capacity to treat opioid use disorder meets the needs of its beneficiaries.\n(2)\nThe Mayor shall submit a report to the Council that includes:\n(A)\nAn analysis of programs in other jurisdictions that have sought to expand access to opioid use disorder treatment medications;\n(B)\nAn evaluation of District health care providers' treatment capacity for opioid use disorders in the District, including opportunities for expanding and improving offerings;\n(C)\nAn identification of any barriers to expanding access to additional opioid use disorder treatment medications;\n(D)\nAn assessment of the financial costs associated with different methods of treating opioid use disorder;\n(E)\nAn assessment of the current reimbursement rates for health care providers for opioid use disorder treatment; and\n(F)\nAn identification and analysis of any gaps in opioid use disorder treatment options in the District.","path":["Title 7. Human Health Care and Safety.","Chapter 32. Opioid Overdose Treatment and Prevention.","Subchapter I. Treatment and Prevention."],"source_url":"https://code.dccouncil.gov/us/dc/council/code/sections/7-3202","current_through":"2026-08-20 (D.C. Law 26-175)","vintage":"","retrieved_at":"2026-08-29T05:44:07Z","sha256":"918b78c71ca34ad5da36d17021becfcade507c9f963576a0bcd934e9ad3582f9","source_id":"us-dc","stale":false,"prev":"us-dc/d.c.-code-7-3201","next":"us-dc/d.c.-code-7-3203"},"notice":"GroundRules: Original legal text. Not legal advice."}